| HOME >> BIOLOGY >> TECHNOLOGY |
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $5,135,644 $408,061
Short-term investments 500,000 250,000
Prepaid expenses and other current assets 52,959 104,526
Total Current Assets 5,688,603 762,587
Property and equipment, net 5,444 7,526
Intangibles, net 2,896,958 2,544,447
Deferred financing costs 748,949 --
Security deposit 7,187 7,187
TOTAL ASSETS $9,347,141 $3,321,747
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $552,026 $109,258
Accrued expenses 368,570 377,359
Deferred revenue 4,167 16,667
Total Current Liabilities 924,763 503,284
Convertible note, net of discount 257,560 --
Grant payable 99,728 99,728
Other liability 26,129 29,196
TOTAL LIABILITIES 1,308,180 632,208
STOCKHOLDERS' EQUITY:
Preferred stock, $0.01 par value;
authorized 5,000,000 shares, no shares issued -- --
Common stock, $0.01 par value;
authorized 100,000,000 shares,
issued and outstanding
17,581,852 and 17,473,694, respectively 175,819 174,737
Capital in excess of par 35,161,399 28,136,342
Deficit accu
'/>"/>
| SOURCE Senesco Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |